Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Hong Kong
· Delayed Price · Currency is HKD 7.38
+0.04 (0.54%)
Apr 29, 2026, 4:08 PM HKT
HKG:3613 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 500.28 | 540.39 | 645.88 | 607.84 | Upgrade
|
| Depreciation & Amortization | - | 85.98 | 80.45 | 73.6 | 69.02 | Upgrade
|
| Other Amortization | - | 2.14 | 2.06 | 1.87 | 0.96 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -2.41 | 0.38 | -0.03 | 0.44 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.05 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -2.88 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | -2.06 | 3.26 | 1.54 | -0.26 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 1.95 | 21.19 | 6.48 | 7.52 | Upgrade
|
| Other Operating Activities | - | -28.78 | -149.7 | 144.97 | 31.62 | Upgrade
|
| Change in Accounts Receivable | - | -116.75 | 492.15 | -434.16 | 23.19 | Upgrade
|
| Change in Inventory | - | -584.26 | -543.6 | -47 | 64.96 | Upgrade
|
| Change in Accounts Payable | - | -73.35 | 17.12 | 154.24 | -28.1 | Upgrade
|
| Operating Cash Flow | - | -217.25 | 460.83 | 547.44 | 777.17 | Upgrade
|
| Operating Cash Flow Growth | - | - | -15.82% | -29.56% | 569.66% | Upgrade
|
| Capital Expenditures | - | -43.17 | -21.87 | -38.51 | -23.43 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0 | 0.06 | 0.13 | 0.02 | Upgrade
|
| Cash Acquisitions | - | - | - | -3.26 | -13.55 | Upgrade
|
| Investment in Securities | - | 1,332 | -1,126 | 362.27 | -234 | Upgrade
|
| Other Investing Activities | - | 65.81 | 69.17 | 14.79 | 5.22 | Upgrade
|
| Investing Cash Flow | - | 1,355 | -1,079 | 335.41 | -265.73 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.39 | Upgrade
|
| Long-Term Debt Repaid | - | -63.97 | -58.73 | -56.48 | -50.66 | Upgrade
|
| Net Debt Issued (Repaid) | - | -63.97 | -58.73 | -56.48 | -50.28 | Upgrade
|
| Common Dividends Paid | - | -276.24 | -276.24 | -234.39 | -200.9 | Upgrade
|
| Other Financing Activities | - | -15.09 | -37.21 | -35.28 | -27.47 | Upgrade
|
| Financing Cash Flow | - | -355.3 | -372.18 | -535.42 | -278.65 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -9.04 | -1.28 | -16.78 | 1.48 | Upgrade
|
| Net Cash Flow | - | 773.26 | -991.15 | 330.66 | 234.26 | Upgrade
|
| Free Cash Flow | - | -260.42 | 438.97 | 508.94 | 753.74 | Upgrade
|
| Free Cash Flow Growth | - | - | -13.75% | -32.48% | 630.55% | Upgrade
|
| Free Cash Flow Margin | - | -16.16% | 28.79% | 29.40% | 48.44% | Upgrade
|
| Free Cash Flow Per Share | - | -0.31 | 0.52 | 0.61 | 0.90 | Upgrade
|
| Cash Interest Paid | - | 6.48 | 5.98 | 4.66 | 4.71 | Upgrade
|
| Cash Income Tax Paid | - | 108.42 | 231.04 | 19.16 | 137.84 | Upgrade
|
| Levered Free Cash Flow | - | -382.46 | 318.64 | 315.94 | 593.34 | Upgrade
|
| Unlevered Free Cash Flow | - | -378.41 | 322.38 | 318.85 | 596.28 | Upgrade
|
| Change in Working Capital | - | -774.35 | -34.32 | -326.91 | 60.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.